Alice Y Chang, MD, MSc, Mayo Clinic, Rochester, MN
Dr. Chang is an Assistant Professor in the Division of Endocrinology, Metabolism, Diabetes, and Nutrition at Mayo Clinic in Rochester, Minnesota. Dr. Chang completed her undergraduate studies at Harvard, received her MD from Yale School of Medicine, trained in Internal Medicine at Brigham and Women’s Hospital and practiced Internal Medicine for five years prior to an endocrinology fellowship. During her endocrinology fellowship at UT Southwestern in Dallas, Texas, she pursued a Master of Science in Clinical Science and became a Scholar Advisor for the UT Southwestern CTSA training program. Dr. Chang’s research focus is cardiometabolic risk in Polycystic Ovary Syndrome (PCOS). She is currently a scholar in the NIH Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) Center at Mayo Clinic. She is past chair of the mentoring committee for Women in Endocrinology and previously served as a member of the Women in Science and Medicine Committee at UT Southwestern. She is a past member of the Research Affairs Committee for the Endocrine Society and current member of the Reproductive Endocrinology Committee for the American Association of Clinical Endocrinologists. Her clinical practice at Mayo Clinic is focused on PCOS and disorders of the pituitary, gonads and adrenal glands.
Kurt Arthur Kennel, M.D., Mayo Clinic, Rochester, MN
Dr. Kennel is an endocrinology fellowship program director. In this capacity he mentors and seeks mentorship for internal medicine residents exploring a career in endocrinology and clinical fellows who are refining their career goals.
Ellen W. Seely, MD, Brigham & Women's Hospital, Boston, MA
Ellen W. Seely, MD is Director of Clinical Research in the Endocrinology, Diabetes and Hypertension Division, Vice Chair for Faculty Development in the Department of Medicine at Brigham and Women’s Hospital, and Professor of Medicine at Harvard Medical School. Her research focus is on unique cardiovascular risk factors in women with an emphasis on the pregnancy complications, preeclampsia and gestational diabetes (GDM). She has demonstrated that women with a history of preeclampsia and women with a history of GDM have increased cardiovascular risk markers, impaired vascular function and altered regulation of the renin- angiotensin-aldosterone system (RAAS) when studied remotely from pregnancy and is working to develop ways to improve this adverse cardiovascular profile. Her research has been supported by the NIH, CDC and PCORI. Dr. Seely has a long term commitment to mentoring clinical investigators and has been recognized for this work by her receipt of an A. Clifford Barger Excellence in Mentoring Award from Harvard Medical School in 2001 and 10 years of K24 Mentoring Funding from the NIH. In addition, she received the 2013 Contribution to Faculty Development and Diversity Award and the 2015 Senior Faculty Mentor Award from Brigham and Women’s Hospital Center for Faculty Development and Diversity. Dr. Seely obtained her MD from Columbia College of Physicians and Surgeons and completed her training in Internal Medicine and Endocrinology and Metabolism at Brigham and Women’s Hospital. She is married to a pulmonologist and has 2 adult children and a dog.
Dana Gaddy, PhD, Texas A&M University, College Station, TX
Dana Gaddy, PhD. is a tenured Professor in the Veterinary Integrative Biosciences Department at Texas A&M University (TAMU). after serving on the faculty for 19 years at the University of Arkansas for Medical Sciences (UAMS). She received her PhD in Cell Biology focused on ovarian function in Dr. JoAnne Richards lab at Baylor College of Medicine, and completed her post-doctoral fellowship on neuroendocrine actions of Activin A at the Salk Institute in the laboratory of the late Dr. Wylie Vale. Dr. Gaddy began her academic career in 1996 at UAMS, where her NIH funded research interests have focused on two major research areas. Her research team was the first to demonstrate the synthesis and activity of Activin A in the bone marrow, report the in vivo bone anabolic effects of Inhibin A, as well as the correlation of circulating Inhibin levels and markers of bone turnover across the menopause transition. Another area of research emphasis of the Gaddy lab has been characterizing the musculoskeletal changes associated with age and disuse, as well as the age-dependent effects of exercise on restoring bone mass and strength. Dr. Gaddy has served the Endocrine Society on its Annual Meeting Steering Committee, and serves the Women in Endocrinology Society as a previous member and Chair of the Communications Committee, and currently is President-Elect. She is currently a member of the Editorial Board of Endocrinology and reviews for all major endocrine and bone-related journals. Dr. Gaddy is current President of Women in Endocrinology and President Elect of the Advances in Mineral Metabolism organization, has previously served as an elected member of the Council of the American Society for Bone and Mineral Research.
Pamela L Mellon, PhD, University of California, San Diego, La Jolla, CA
Pamela Mellon received her Ph.D. in Molecular Biology at UC Berkeley in 1975. As a postdoctoral fellow with Tom Maniatis, at Cal Tech then Harvard, she invented the technology of transient transfection into cultured cells to study mammalian gene expression and was first to demonstrate that transiently transfected genes were tissue-specifically and developmentally regulated. As Assistant Professor at The Salk Institute, she studied glycoprotein hormones in reproduction. She developed hypothalamic neuronal cell lines and model systems for pituitary gonadotropes and thyrotropes using transgenic mice and advanced mouse model systems for endocrine, paracrine and autocrine functions. Moving to UCSD in 1992, Dr. Mellon has established mechanisms of action of pulsatile GnRH, activin, and steroids on pituitary and hypothalamic gene expression. Her research program has provided seminal advances in understanding of developmental and hormonal regulation of pituitary gonadotropin genes and hypothalamic gonadotropin-releasing hormone gene in vitro and in vivo. Dr. Mellon is Vice-Chair for Research in the Dept. of Reproductive Medicine, the Director of the UCSD NIH U54 Center for Reproductive Science and Medicine, the NIH Postdoctoral Training Grant "Training in Reproductive Sciences", the UCSD NICHD Women’s Reproductive Health Research Center (NICHD K12), and the Transgenic and Knockout Mouse Core supported by three additional Center grants. She has published 142 peer-reviewed papers and trained 50 postdoctoral fellows, 20 PhD students, 24 Master’s, and 94 undergraduates. She was President of Women in Endocrinology, a member of the Council of the Endocrine Society, and has served as Chair of the NIH Endocrinology Study Section, as well as on numerous Editorial and Foundation Boards. She is the recipient of the Richard E. Weitzman Memorial and the Ernst Oppenheimer Memorial Awards of the Endocrine Society, an NIH MENTOR Award, the Women in Endocrinology Mentor Award, the UCSD Chancellor's Postdoctoral Mentoring Award, and an NIH MERIT Award.
After this session, attendees will be able to:
- Understand how to be an effective mentor by giving constructive criticism and facilitating effective communication.
- Understand, as a mentor, the individual needs of the mentee and how to adapt to different learning styles.
- Understand how to be a good mentee by building an effective relationship through communication and asking questions.
- Understand how to collaborate with their mentor to develop a strong career development plan.